Chewable Tablets For Asthma and Allergies Get FDA Approval

Montelukast Sodium chewable tablets formulated by Jubilant Life Sciences relieve symptoms of seasonal allergies and treats asthma.

Montelukast Sodium chewable tablets used in the treatment of asthma and to relieve symptoms of seasonal allergies developed by Jubilant Life Sciences received final approval for the generic from the US health regulator.

Jubilant Life //Sciences said in a statement, "The company has received abbreviated new drug application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Montelukast Sodium chewable tablets of 4 mg and 5 mg.”

Asthma - Factors, Common Allergens, Diagnosis, Treatment, Support Groups, FAQs
It's a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it

The company had a total of 781 filings for formulations of which 333 have been approved in various regions globally and includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, it has received 10 ANDA approvals during FY2015.

"The total market size for Montelukast tablets as per IMS is USD 83 million per annum," Jubilant Life Sciences said. The tablets are generic version of Merck's Singulair chewable tablets used for the treatment of asthma and to relieve symptoms of seasonal allergies, it added.

Source-Medindia

Asthma Drug Approved in UK for Adults and Children Between 6-11 Yrs
Omalizumab, the life saving asthma drug has been approved for the treatment of asthma by NICE in the United Kingdom.

Tests for Asthma - Medical and Family History, Diagnosis & Treatment
Do you find it difficult to breathe especially during the cold weather? You may need to get tested for asthma, a respiratory condition that is induced by allergies.